Global Primary Immunodeficiency Diseases Marketwas valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.
Global Primary Immunodeficiency Diseases Market
Global Primary Immunodeficiency Diseases Market Drivers and Restrains Primary immunodeficiencies are disorders in which part of the body's immune system is missing or does not function normally. To be considered a primary immunodeficiency (PID), the cause of the immune deficiency must not be secondary in nature (i.e., caused by other disease, drug treatment, or environmental exposure to toxins). Most primary immunodeficiencies are genetic disorders; the majority are diagnosed in children under the age of one, although milder forms may not be recognized until adulthood. Rising prevalence of diseases such as selective IgA deficiency, and IgG subclass deficiency worldwide is fueling the Global Primary Immunodeficiency Diseases Market .The sideeffects such as renal failure and allergic reactions associated with the treatment could hamper the Global Primary Immunodeficiency Diseases Market during forecast period. High-cost of the therapies is considered to be major restraint for global market.
Global Primary Immunodeficiency Diseases Market key segmentation Global Primary Immunodeficiency Diseases Market is segmented by Disease, Test and Treatment. Based on disease the market is divided in to Antibody Deficiency, Cellular Immunodeficiency and Innate Immune Disorders. Antibody Deficiency is further sub-divided into Agammaglobulinaemia (XLinked and Autosomal Recessive), Common Variable Immune Deficiency, Selective IgA Deficiency IgG